Peter Attia· MD
so you need to use on10th of the maale dose because that's probably what gets you to this physiologic range that I was talking about yeah
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so you need to use on10th of the maale dose because that's probably what gets you to this physiologic range that I was talking about yeah
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
you want to use one1 of the M dose the position papers that I've been involved with state that
Why isn't a female formulation being made? Buckle up, buttercup. So here we go. We had a billion dollars that was put into it. A billion dollars in a five-year study that was done at the FDA and it showed it was safe. It showed that it was effective. It showed that it was fine. It wasn't that Here's the the the TLDDR on testosterone is it's not that serious, right? We want it to be serious. Again, not a feeling. We want it to be like all about aggression. It's not a feeling. Like it truly isn't. Um and so they did five years of study. A billion dollars went into it and the FDA came back and they said, "Oo, women have breast tissue, so we're going to need five more years of data and another billion dollar study and every company was like, I'm out." Right. The benchmark was different for women. Men, six months. And this was a real goalpost move. Yeah. They just keep moving the damn goalpost.